Pfizer and rival Moderna both asked U.S. regulators this week to authorize modified versions of their booster vaccine — shots that are half the original recipe and half protection against BA.4 and BA.5, the newest versions of omicron.
from New York Daily News https://ift.tt/NdOiMcv
No comments:
Post a Comment